Search clinical trials for: Rosiglitazone

Total 231 results

Novartis

Completed

Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Germany
China Medical University Hospital

Completed

Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy

Type 2 Diabetes Mellitus With Features of Insulin Resistance

Taiwan
National Cheng-Kung University Hospital

Completed

Role of Rosiglitazone on Pre-Diabetes Mellitus and Coronary Artery Disease

Coronary Artery Disease | Insulin Resistance | Glucose Intolerance | Prediabetes
University of Texas Southwestern Medical Center
GlaxoSmithKline; Biosite

Completed

Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Terminated

An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

China
University of Massachusetts, Worcester
GlaxoSmithKline

Completed

Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue (RAPA)

Metabolic Syndrome | Insulin Resistance

United States
GlaxoSmithKline

Completed

A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

Healthy Subjects | Anaemia

Australia
Takeda
Eli Lilly and Company

Completed

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Diabetes Mellitus

United States
Takeda

Completed

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. (COMPLEMENT)

Diabetes Mellitus

United States, Puerto Rico
Brooke Army Medical Center
InterMune

Completed

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

Hepatitis C

United States
Technische Universität Dresden

Completed

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Type 2 Diabetes | Overt Diabetic Nephropathy

Germany
Hadassah Medical Organization

Unknown

Prevention of Corticosteroid-induced Glucose Intolerance

Glucose Intolerance

Israel
Creighton University

Completed

The Use of Rosiglitazone to Treat Asthma

Asthma

United States
Seoul St. Mary's Hospital
GlaxoSmithKline

Terminated

Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH

NASH (Non-alcoholic Steato-hepatitis)
VIVUS LLC

Completed

Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects

Erectile Dysfunction
University of Washington
GlaxoSmithKline; National Institute on Aging (NIA)

Unknown

Rosiglitazone Effects on Cognition for Adults in Later Life (RECALL)

Mild Cognitive Impairment

United States
Korea University Anam Hospital

Completed

The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome

Metabolic Syndrome

Korea, Republic of
FibroGen

Completed

Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects

Healthy Adult Subjects
University of Aarhus

Completed

The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells

Change in Bone Mineral Density | Change in Bone Marrow Fat Content

Denmark
Bristol-Myers Squibb

Completed

Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone

HIV Infections

United States
Intermountain Health Care, Inc.
GlaxoSmithKline

Terminated

Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study

Coronary Artery Disease

United States
Sanofi

Completed

Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy

Type 2 Diabetes Mellitus

United States
Radboud University Medical Center

Completed

The Influence of Rosiglitazone on the Diuretic Effect of Furosemide and Amiloride

Insulin Resistance

Netherlands
Radboud University Medical Center
GlaxoSmithKline

Completed

The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.

Ischemia-Reperfusion Injury | The Metabolic Syndrome

Netherlands
GlaxoSmithKline

Completed

Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes

Type 2 Diabetes Mellitus
Hospital Authority, Hong Kong

Unknown

Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?

Cardiovascular Diseases | Kidney Diseases | Chronic Disease

China
Vertex Pharmaceuticals Incorporated

Completed

Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770

Cystic Fibrosis

United States
Solvay Pharmaceuticals

Completed

A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers

Type 2 Diabetes Mellitus

United Kingdom
National Institute of Diabetes and Digestive and...

Completed

Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome

HIV Infections | Insulin Resistance | Lipodystrophy

United States
University of Leipzig

Completed

Physical Exercise Versus Rosiglitazone in CAD and Prediabetes

Impaired Glucose Tolerance
University of Glasgow
GlaxoSmithKline; Chief Scientist Office of the Scottish Government; Chest, Heart...

Completed

Rosiglitazone Versus Theophylline in Asthmatic Smokers

Asthma

United Kingdom
University of British Columbia

Completed

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

HIV Infections | Atherosclerosis

Canada
University of Arkansas

Completed

Effect of Thiazolidinedione Treatment Vascular Risk Markers

Vascular Diseases | Diabetes Mellitus, Type 2

United States
Gerstein, Hertzel, MD
Wyeth is now a wholly owned subsidiary of Pfizer; GlaxoSmithKline; Canadian Institutes... and other collaborators

Completed

The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial

Glucose Metabolism Disorders | Cardiovascular Disease | Impaired Glucose Tolerance
Universiti Sains Malaysia
Ministry of Health, Malaysia

Completed

To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients

Diabetes | Impaired Glucose Tolerance

Malaysia
Brooke Army Medical Center

Unknown

Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis

United States
GlaxoSmithKline

Completed

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

Non-Insulin-Dependent Diabetes Mellitus
University of Glasgow
GlaxoSmithKline; British Heart Foundation

Terminated

Rosiglitazone Versus Placebo in Chronic Stable Angina

Angina Pectoris | Metabolic Syndrome X

United Kingdom
US Department of Veterans Affairs

Completed

Insulin, Neurogenetics and Memory in Alzheimer's Disease

Alzheimer Disease

United States
National Taiwan University Hospital
National Science Council, Taiwan

Suspended

The Impact of Rosiglitazone on Regression of Atherosclerosis

Diabetes Mellitus, Atherosclerosis

Taiwan
AstraZeneca

Completed

Drug Interaction Study Between AZD3480 and Cytochrome P450 (Cocktail)

Alzheimer's Disease | Metabolism

Sweden
University of Calgary
GlaxoSmithKline

Terminated

Glitazones and Endothelial Function (GATE)

Diabetes Mellitus

Canada
GlaxoSmithKline

Completed

Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

Type 2 Diabetes Mellitus | CV Risk
Pfizer

Terminated

Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone

Type 2 Diabetes Mellitus

Israel
Laval University
GlaxoSmithKline

Completed

Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial (VICTORY)

Diabetes | Coronary Artery Bypass Grafting

Spain, Canada
Leiden University Medical Center

Terminated

Rosiglitazone and Insulin Resistance in Renally Impaired Patients

Insulin Resistance | Chronic Kidney Disease

Netherlands
Leiden University Medical Center

Withdrawn

Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease (Hercules)

Inflammation | Chronic Kidney Disease

Netherlands
University of Texas Southwestern Medical Center
GlaxoSmithKline

Completed

Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving Rosiglitazone

Insulin Sensitivity

United States
Gerstein, Hertzel, MD
Heart and Stroke Foundation of Ontario

Completed

The Study of Atherosclerosis With Ramipril and Rosiglitazone

Cardiovascular Disease | Atherosclerosis | Impaired Glucose Tolerance | Isolated Impaired Fasting Glucose
Denver Research Institute
GlaxoSmithKline

Unknown

Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance

Impaired Glucose Tolerance

United States

Search clinical trials for: Rosiglitazone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations